MLchartDataset catalogue

Glisoxepide

Term · Oncology and biomedicine · MLC-T-ONC-013965

A second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, glisoxepide exerts greater binding affinity than the first-generation compounds. Glisoxepide shows peroxisome proliferator-activated receptor (PPAR) gamma agonistic activity, has a short half-life and is excreted in both the bile and urine.

Table 1. Record
IdentifierMLC-T-ONC-013965
FieldOncology and biomedicine
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-013965",
  "term": "Glisoxepide",
  "field": "Oncology and biomedicine",
  "definition": "A second-generation sulfonylurea with antihyperglycemic activity. Like other second-generation compounds, glisoxepide exerts greater binding affinity than the first-generation compounds. Glisoxepide shows peroxisome proliferator-activated receptor (PPAR) gamma agonistic activity, has a short half-life and is excreted in both the bile and urine.",
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/glisoxepide/"
}

Record 8,027 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.